Clinical Trial: Phase III ALTU-135 CP Safety Trial

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title: An Open-Label Clinical Study Evaluating the Long Term Safety of ALTU-135 in the Treatment of Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis or

Brief Summary: This is an open-label, single-arm clinical study investigating the long-term safety of ALTU-135 treatment in Chronic Pancreatitis (CP) patients with exocrine Pancreatic Insufficiency (PI).

Detailed Summary:
Sponsor: Anthera Pharmaceuticals

Current Primary Outcome: Number of participants with an adverse event [ Time Frame: Baseline up to 12 months ]

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Anthera Pharmaceuticals

Dates:
Date Received: July 10, 2007
Date Started: December 2007
Date Completion:
Last Updated: October 15, 2014
Last Verified: October 2014